PixarBio Corporation has been launched to research and develop novel biomaterials for long term-personalized drug delivery systems for Parkinson’s Disease.PixarBio’s founding team includes InVivo Therapeutics co-founders Frank Reynolds, and Robert S.
No comment yet.
Sign up to comment